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E-CIGARETTE REGULATION IN CHINA: THE ROAD AHEAD 
 
Eric A. Feldman,* Chai Yue†
 
 
The global electronic cigarette industry has exploded in the 
past decade—from $20 million in sales in 2008 to an estimated $7 
billion in 2014—and China has been an essential part of that growth.1  
As the world's largest consumer of combustible tobacco products, 
accounting for about one-third of the global market.  China is also a 
prime contender to become the largest consumer of electronic 
cigarettes.  These simple facts raise a critical question—what should 
the Chinese government do about regulating electronic cigarettes? 
So far, the regulation of electronic cigarettes in China has 
attracted scant attention. 2   This paper begins to fill that gap by 
identifying the key issues confronting regulators in China and 
suggesting a way forward.  It first describes the origin and 
development of e-cigarettes in China and then discusses the current 
regulatory status of e-cigarettes.  Because two of the key regulatory 
options Chinese regulators are likely to consider—treating electronic 
cigarettes as tobacco products or as pharmaceutical products—
represent the approaches of the United States and Japan respectively, 
the paper discusses e-cigarette regulation in those countries and 
analyzes its relevance to China.  The paper concludes by suggesting 
that regardless of whether Chinese regulators decide to treat e-
cigarettes as tobacco products or pharmaceuticals, there are a 
number of areas that invite immediate regulatory action.  They 
include the dubious health claims made by many e-cigarette 
companies, such as suggesting that e-cigarettes are good for one’s 
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1 Electronic Cigarette Statistics, STAT. BRAIN RES. INST. (Mar. 2, 2016), http://www.
statisticbrain.com/electronic-cigarette-statistics/; Martinne Geller, Special Report: When It 
Comes to E-cigs, Big Tobacco Is Concerned for Your Health, REUTERS (Mar. 23, 2015), 
http://www.reuters.com/article/2015/03/23/us-ecigarettes-regulations-specialreport-
idUSKBN0MJ0GN20150323. 
2 Yan Dingfei (严定非), Dianzi Yan: Silue Zai Wuzhu Zhi Di (电子烟:肆虐在无主之
地) [E-cigarettes Are Raging in No Man’s Land], SOUTHERN WEEKEND (Mar. 24, 2015), 
http://www.infzm.com/content/102764. 
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health, and the lack of quality control provisions governing the 
electronic cigarette manufacturing process.  More generally, tobacco 
control measures targeted at combustible cigarettes should be 
strengthened to better control combustible tobacco consumption and 
address the increased use of e-cigarettes.  Priority should be placed 
on regulating sales to youth. 
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The global electronic cigarette industry has exploded in the 
past decade—from $20 million in sales in 2008 to an estimated $7 
billion in 2014—and China has been an essential part of that growth.3  
A Chinese chemist in 2003 developed the first e-cigarette, and China 
quickly emerged as the world’s largest manufacturer of e-cigarettes, 
currently responsible for over 90% of global e-cigarette production.4  
As the world's largest consumer of combustible tobacco products, 
accounting for about one-third of the global market, China is also a 
prime contender to become the largest consumer of electronic 
                                                                                                               
3  Electronic Cigarette Statistics, STAT. BRAIN RES. INST. (Mar. 2, 2016), 
http://www.statisticbrain.com/electronic-cigarette-statistics/; Martinne Geller, Special 
Report: When It Comes to E-cigs, Big Tobacco Is Concerned for Your Health, REUTERS (Mar. 
23, 2015), http://www.reuters.com/article/2015/03/23/us-ecigarettes-regulations-special
report-idUSKBN0MJ0GN20150323. 
4 Most e-cigarettes are manufactured in Shenzhen Provence.  The Chinese electronic 
cigarette market is expected to reach 9.6 billion Yuan in three years, according to the 
Engineering Institute of the lithium battery industry, a private think tank with a focus on 
strategic emerging industries in China. Dianzi Yan Shichang San Niannei Guimo Jiang Da 
96 Yi Yuan (电子烟市场三年内规模将达 96 亿元) [The Electronic Cigarette Market Is 
Expected to Reach 9.6 Billion Yuan in Three Years], GAOGONGLI DIAN (高工锂电 ) 
[ENGINEERING INSTITUTE OF THE LITHIUM BATTERY INDUSTRY] (Dec. 3, 2013), 
http://www.gg-lb.com/asdisp2-65b095fb-11448-.html. 
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cigarettes.  These simple facts raise a critical question—what should 
the Chinese government do about regulating electronic cigarettes? 
So far, the regulation of electronic cigarettes in China has 
attracted scant attention. 5   This paper begins to fill that gap by 
identifying the key issues confronting regulators in China and 
suggesting a way forward.  It first describes the origin and 
development of e-cigarettes in China and then discusses the current 
regulatory status of e-cigarettes.  Because two of the key regulatory 
options Chinese regulators are likely to consider—treating electronic 
cigarettes as tobacco products or as pharmaceutical products—
represent the approaches of the United States and Japan respectively, 
the paper discusses e-cigarette regulation in those countries and 
analyzes its (relevance to China.  The paper concludes by suggesting 
that regardless of whether Chinese regulators decide to treat e-
cigarettes as tobacco products or pharmaceuticals, there are a number 
of areas that invite immediate regulatory action.  They include the 
dubious health claims made by many e-cigarette companies, such as 
suggesting that e-cigarettes are good for one’s health, and the lack of 
quality control provisions governing the electronic cigarette 
manufacturing process.  More generally, tobacco control measures 
targeted at combustible cigarettes should be strengthened to better 
control combustible tobacco consumption and address the increased 
use of e-cigarettes.  Priority should be placed on regulating sales to 
youth. 
We are attentive to the fact that e-cigarette regulation in China 
will be shaped to some degree by the nation’s high rate of 
combustible tobacco consumption, the economic importance of 
tobacco as a source of tax revenue, and the public health 
consequences of its high smoking rate.  Public health policy always 
involves both predictions and tradeoffs, and government regulators 
will have to assess the potential costs and benefits of more or less 
aggressive e-cigarette regulation.  Nonetheless, we argue in this paper 
that continued regulatory inaction is not viable.  It is time for China—
like the United States, Japan, the EU, and many other jurisdictions—
to engage e-cigarettes and craft a regulatory strategy, even one that is 
likely to be imperfect.  
 
                                                                                                               
5 Yan Dingfei (严定非), Dianzi Yan: Silue Zai Wuzhu Zhi Di (电子烟:肆虐在无主之
地) [E-cigarettes Are Raging in No Man’s Land], SOUTHERN WEEKEND (Mar. 24, 2015), 
http://www.infzm.com/content/102764. 
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I. THE ORIGIN AND DEVELOPMENT OF E-CIGARETTES IN 
CHINA 
 
In 2003, Han Li (韩力 ), a pharmacist from the Liaoning 
Chinese Medicine Research Institute, obtained a patent for “A 
Flameless Electronic Atomizing Cigarette.”6  Later named “RuYan” 
(如烟), which in Chinese is evocative of a romantic ephemerality,7 
the first e-cigarettes hit the market in China in 2004, with exports by 
the Golden Dragon Group of Hong Kong starting the following year.  
RuYan was quickly copied by new companies that entered the e-
cigarette market.  Although the products were eventually 
differentiated by shape, color, and size, all of them used the same 
basic technology, consisting of a prefilled or refillable cartridge 
containing liquid nicotine and other ingredients (e-liquid), an 
atomizer, a heating element, and a battery.8  Inhaling on an e-cigarette 
heats the e-liquid and creates vapor, which mimics the effect of 
smoking traditional tobacco products. 
In recent years, e-cigarette consumption in China has 
increased rapidly.9   According to the China Domestic E-cigarette 
Market Analysis, an industry report published in November 2014, the 
average rate of e-cigarette use was 3.4% among smokers in five 
representative cities including Beijing, Shanghai, Xi’an, Guangzhou 
                                                                                                               
6 Yi Zhong Fei Keranxing Dianzi Wu Hua Xiangyan (一种非可燃性电子雾化香烟) [A 
Flameless Electronic Atomizing Cigarette], China Patent No. 031111734 (filed Mar. 14, 
2003),  http://cpquery.sipo.gov.cn/txnQueryBibliographicData.do?select-key:shenqingh=03
1111734&select-key:backPage=http%3A%2F%2Fcpquery.sipo.gov.cn%2FtxnQuery
OrdinaryPatents.do%3Fselect-key%3Ashenqingh%3D031111734%26select-key%3
Azhuanlimc%3D%26select-key%3Ashenqingrxm%3D%26select-key%3Azhuanlilx%3D
%26select-key%3Ashenqingr_from%3D%26select-key%3Ashenqingr_to%3D%26inner-
flag%3Aopen-type%3Dwindow%26inner-flag%3Aflowno%3D1442572578938&inner-
flag:open-type=window&inner-flag:flowno=1442572597279. 
7  The name “RuYan,” meaning “just like tobacco/smoke,” was carefully chosen.  
Characters named RuYan appear in various romantic novels, songs, and movies thick with 
nostalgia for the “good old days,” and there is an elegant fictional female character called 
Miss RuYan who appears in various media. 
8  They are also now differentiated by name, with some called e-cigarettes, others 
vaporizers, and still others vaping pens or e-hookahs.  
9 China Central Television, for example, reported in 2015 that the consumption of e-
cigarettes was booming and sales were increasing annually. Dianzi Yan Qinru Xiaoyuan 
Shou Xuesheng Zhuipeng, Yizhi Nigu Ding Shangying (电子烟“侵入”校园,易致尼古丁
上瘾) [E-cigarettes "Invade" the Campus and Are Popular Among Students], CCTV NEWS 
(May 7, 2015), http://m.news.cntv.cn/2015/05/07/ARTI1430961909196900.shtml. 
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and Harbin.10  E-cigarettes use among minors has also taken hold.  A 
May 2014 survey by the Chinese CDC indicated that of 155,117 
junior high school students (age 13–15) across 31 provinces, 45% had 
heard of e-cigarettes, and 1.2% had used them in the past thirty 
days.11  The use of e-cigarettes among youth has been noted by the 
mass media, with one news report focusing on the sale of e-cigarettes 
as toys at the entrance of a primary school and others describing the 
preference for fruit flavors among youth and the concerns of parents 
about their children who use e-cigarettes.12 
Market data also tell a story of increased e-cigarette 
consumption.  In 2013, with a growth rate of 150%, China’s domestic 
e-cigarette market reached ¥ 3.5 billion.13  In 2014, the market also 
witnessed a growth spurt, with both sales and the number of users 
increasing by 263% and 259% respectively over the previous year.14  
Over the next five to ten years, according to industry researcher Xia 
                                                                                                               
10 However, the sample size was quite small (500 people in each city). Clearly, more 
data are needed. Dianzi Yan Guonei Shichang Fenxi (电子烟国内市场分析) [China 
Domestic E-cigarette Market Analysis], CECMOL (Nov. 14, 2014), http://www.cecmol.
com/news/show-3344.html. 
11 2014 Zhongguo Qingshaonian Yancao Diaochao Baogao (2014 中国青少年烟草报
告) [China Youth Tobacco Survey], CHINESE CTR. FOR DISEASE CONTROL AND PREVENTION 
(May 2015), http://www.tcrc.org.cn/UploadFiles/2015-07/251/2015070910174559651.pdf. 
12 Hefei Yi Xiaoxue Menkou Dianziyan Dang Wanju Mai, Laoban Cheng Mei Weihai 
(合肥一小学门口“电子烟”当玩具, 老板称没危害) [E-cigarettes Are Sold as Toys at 
the Entrance of a Primary School, but the E-cigarettes Owner Asserts No Harm], ZHONG’AN 
ZAIXIAN (Feb. 9, 2015), http://news.ifeng.com/a/20150209/43131134_0.shtml; Yizhong 
Daiyou Guowei De Dianziyan Zai Xuesheng Zhong Liuxing Dan Weifa (一种带有果味的
“电子烟”在学生中流行但违法) [Fruit-Flavored E-cigarettes Popular Among Students], 
NANTONG DAILY (Jan. 13, 2015), http://www.js.xinhuanet.com/2015-01/13/c_1113978067.
htm; Haizi Chou Dianziyan Ling Jiazhang Youxin, Zhuanjia: Cilei Shangpin Hui Wudao 
Weichengnianren (孩子抽“电子烟”令家长忧心专家:此类商品会误导未成年人) 
[Parents Are Concerned About Children Using E-cigarettes. Expert Said This Kind of 
Product Will Misguide Minors], TAIZHOU EVENING NEWS (Jan. 28, 2015), 
http://www.tznews.cn/2013/news/shehui/2015/01/2015-01-28220752.html. 
13 Dianzi Yan Shichang San Niannei Guimo Jiang Da 96 Yi Yuan (电子烟市场三年内
规模将达 96 亿元) [The Electronic Cigarette Market Is Expected to Reach 9.6 Billion Yuan 
in Three Years], GAOGONGLI DIAN (高工锂电) [ENGINEERING INSTITUTE OF THE LITHIUM 
BATTERY INDUSTRY] (Dec. 3, 2013), http://www.gg-lb.com/asdisp2-65b095fb-11448-.html. 
14 An interview by the China Medicine Economic Newspaper, sponsored by the China 
Food and Drug Administration Southern Medicine Economic Institute, provides these 
figures. Guonei Dianziyan Shichang Xushi Daifa (国内电子烟市场蓄势待发) [Domestic 
Electronic Cigarette Market Is Ready], MED. ECON. NEWS (Jan. 19, 2015), http://www.
yyjjb.com/html/2015-01/19/content_219407.htm. 
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Long, “the market compound growth rate will exceed 30%.” 15  
Taobao, the largest online Business-to-Customer platform and an 
important venue for the sale of e-cigarettes,16 was the site of $22 
million USD in sales of the top ten brands of e-cigarettes in 2014.17  
Although the overall number of e-cigarette consumers in China and 
gross sales are still relatively modest, analysts speculate that in the 
upcoming decades, they will overtake the popularity of conventional 
combustible cigarettes.18 
Indeed, the potential market for such products in China is vast.  
For every 1% rate of substitution of e-cigarettes for combustible 
cigarettes, the Chinese e-cigarette market will increase by almost $5 
billion USD.19  Moreover, China Tobacco (also known as the State 
Tobacco Monopoly Administration) began to research and develop 
its own e-cigarette product in 2013.  In 2014, China Tobacco of Hubei, 
a provincial subsidiary of the national tobacco monopoly China 
Tobacco, launched its first series of e-cigarette products in Wuhan, 
which marked China Tobacco’s formal entry into the e-cigarette 
business.20 
The involvement of China Tobacco in the e-cigarette business 
is a significant event.  As the government’s key tobacco-related 
agency, it is responsible for almost all aspects of the tobacco industry, 
including tobacco growth, production, sales, human resources, 
finance, marketing, and trade.  It includes thirty-three provincial 
Tobacco Monopoly Administrations (provincial tobacco monopoly 
subsidiary corporations), sixteen industrial companies, fifty-seven 
cigarette industrial enterprises, more than 1,000 commercial 
                                                                                                               
15 Dianziyan Zaoyu Binghuo Liangchongtian (电子烟遭遇冰火两重天) [E-cigarettes 
Encounter Ice and Fire], TECH. DAILY (Sep. 2, 2014), http://scitech.people.com.cn/n/
2014/0902/c1007-25585378.html. 
16 Woguo Dianzi Yan Hangye Shichang Zhuangkuang Fenxi (我国电子烟行业市场状
况分析) [Analysis of the E-cigarette Market in China], TIANYA.CN (May 20, 2014), http://
bbs.tianya.cn/post-141-628048-1.shtml.  
17 Dianziyan Zaoyu Binghuo Liangchongtian, supra note 15.  
18 See Zhongguo Ban Jinyanling Dianziyan You Shangji (中国颁禁烟令,电子烟有商
机) [China Bans on Combustible Cigarette, E-cigarette Will Have Business Opportunities], 
SHENZHEN ECON. DAILY (Jan. 17, 2014), http://szsb.sznews.com/html/2014-01/17/content_
2756998.htm (stating that e-cigarettes are not very common in the Chinese market, but in 
the next ten years, the sales of e-cigarettes will exceed the sales of ordinary cigarettes). 
19 Dianziyan Zaoyu Binghuo Liangchongtian, supra note 15. 
20 Mark O’Neill, How China is Lighting up the E-cigarette Market, EJINSIGHT (Aug. 11, 
2014), http://www.ejinsight.com/20140811-china-e-cigartte/. 
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enterprises, and over 510,000 employees.21  Additionally, more than 
20 million people in China are directly linked to the tobacco industry, 
including 1.3 million farming households and 5 million retailers, who 
are all under the supervision of the Monopoly Administration.22  With 
China’s massive government tobacco monopoly setting its sights on 
the e-cigarette market, and the rapid growth of private sector 
manufacturers (the number of e-cigarette enterprises more than 
doubled in 2013), the use of e-cigarettes in China could become 
staggering.23 
The advertising and promotion of e-cigarettes in China, not 
always truthful, has both contributed to their increased popularity and 
illustrated the need for regulation.  RuYan, for example, was 
promoted as a lower-risk alternative to conventional cigarettes.  The 
manufacturer claimed that RuYan contained neither tar nor 
carcinogens24 and that it qualified as a nicotine replacement therapy 
that would enable smokers of combustible cigarettes to kick their 
tobacco addiction.25  Other e-cigarette manufacturers, attentive to the 
increasing social awareness about the health harm of combustible 
tobacco products, have ignored the lack of data on the health impact 
of e-cigarettes and marketed their products as "healthy,” “low harm," 
and "helpful to quit smoking."26 
Because e-cigarettes are so new, scientists are still evaluating 
their impact on public health.  Studies are underway, but at this point 
                                                                                                               
21  Zhongguo Yancao Hangye Gaikuang (中国烟草行业概况 ) [Chinese Tobacco 
Industry Overview], CHINA TOBACCO, http://www.tobacco.gov.cn/html/10/1004.html (last 
visited Oct. 12, 2016). 
22 Zhongguo Yancao Kongzhi Guihua [2012-2015] (中国烟草控制规划 [2012-2015
年]) [China Tobacco Control Plan (2012-2015)], CHINA TOBACCO, http://www.tobacco.
gov.cn/history_filesystem/2013yckz/ghqw2.htm (last visited Oct. 12, 2016).  
23 According to the Engineering Institute of the lithium battery industry, a private think 
tank with a focus on strategic emerging industries in China, the electronic cigarette market 
is expected to reach 9.6 billion Yuan by 2018.  GAOGONGLI DIAN, supra note 4. 
24 The claim regarding the absence of tar is correct, but the absence of carcinogens is 
more complicated.  Most experts agree that e-cigarettes are significantly less carcinogenic 
than combustible tobacco, but they also agree that e-cigarettes contain certain ingredients 
that are carcinogenic.   
25 Ruyan – Jiujing Shi Shenme Yan? (“如烟”－－究竟是什么“烟”?) [RuYan—
What Is RuYan After All?], PEOPLE’S DAILY (Dec. 18, 2006), http://news.xinhuanet.
com/life/2006-12/18/content_5503100.htm.  
26 Li Baojiang (李保江), Zhongguo Yancao Zhongshui Zhengce dui Zengjia Zhengfu 
Shouru he Jianxiao Yancao Xiaofei de Yingxiang (中国烟草重税政策对增加政府收入和
减少烟草消费的影响) [Effects of Increasing Tobacco Taxes on Government Revenue and 
Consumption in China], 16 ACTA TABACARIA SINICA, no. 5, 2010, at 82. 
416 U. PA. ASIAN L. REV.                         [Vol. 11 
 
the only conclusion justified by the evidence is that no one knows 
whether e-cigarettes are harmful to users or to bystanders.  Nor is it 
clear whether they will serve as a useful smoking cessation tool or 
will be a gateway to the use of combustible cigarettes.  As the World 
Health Organization succinctly stated in a recent bulletin, “there are 
only a few studies on the health risks and we don’t know the long-
term effects; for now the evidence is inconclusive about whether 
ENDS [electronic nicotine delivery systems, i.e., e-cigarettes] can be 
an effective smoking cessation aid.”27   A recent panel of experts 
convened by the U.S. National Institute of Health similarly concluded 
that the short-term and long-term effects of e-cigarettes on human 
physiology and behavior are uncertain, and that there is very limited 
data directly addressing whether e-cigarettes reduce combustible 
tobacco consumption.28  In short, although e-cigarettes are a multi-
billion-dollar global industry, the scientific evidence regarding their 
impact on individual and public health remains limited. 
 
II. REGULATORY INACTION OVER E-CIGARETTES IN CHINA 
 
Despite the rapid growth of China’s e-cigarette industry and 
the interest Chinese consumers have shown in e-cigarettes, the 
manufacture, sale, and use of e-cigarettes in China remains largely 
unregulated.  Indeed, each of the agencies that might plausibly 
exercise some regulatory control over e-cigarettes appears to be 
studiously avoiding a leadership role.  Their reluctance to engage the 
regulation of e-cigarettes has been evident since RuYan appeared on 
the market in 2006. 
During a press conference held by the Ministry of Health 
(now the National Health and Family Planning Commission) in May 
2006, for example, a journalist from the China Daily asked whether 
the Ministry would regulate RuYan as a smoking cessation product.29  
                                                                                                               
27 Countries Vindicate Cautious Stance on E-cigarettes, 92 BULL. WORLD HEALTH ORG. 
856, 856-857, WORLD HEALTH ORGANIZATION [WHO] (2014), http://www.who.int/bulletin/
volumes/92/12/14-031214/en/. 
28 Kevin Walton et al., NIH Electronic Cigarette Workshop: Developing a Research 
Agenda, 17 NICOTINE & TOBACCO RES. 259, 260 (2014). 
29 Weishengbu “2006 Nian Zhongguo Xiyan Yu Jiankang Baogao” Fabuhui Neirong 
Shilu – Kongyan Yu Fang’ai Fangzhi (卫生部《2006 年中国“吸烟与健康”报告》发布
会内容实录——控烟与防癌防治) [Press Conference Record of “Smoking and Health” 
Report in 2006 by Ministry of Health—Tobacco Control and Prevention of Lung Cancer], 
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The deputy director of the Maternal Child and Community Health 
Division responded by saying that the main ingredient of RuYan was 
nicotine, a product defined as a “dangerous chemical” that should be 
regulated by the State Council under its Dangerous Chemicals 
Regulations.30  Moreover, the official continued, the regulation of 
RuYan implicated a number of other ministries: the State 
Administration of Work Safety was responsible for manufacturing 
safety, the State Administration for Industry and Commerce was 
responsible for advertising, and the Ministry of Health was 
responsible for safety and toxicological tests.  Together, in the 
official’s view, these authorities were responsible for regulating e-
cigarettes. 
That same year, China Tobacco echoed the view that RuYan 
should be regulated under the State Council’s Dangerous Chemicals 
Regulations, which distanced it from e-cigarette regulation. 31  
Officials from other ministries were similarly evasive.  In a series of 
assertions reminiscent of Rashomon, those from the State 
Administration of Work Safety stated: “It’s true that the production 
and transportation of dangerous chemicals should be under our 
supervision, however, a product which uses a dangerous chemical 
and may cause harm to people should be regulated by other relevant 
government authorities who are responsible for products.  We’re 
asking for instructions from our superior officials.”  According to 
officials from the Advertising Department in the State Administration 
for Industry and Commerce, "Since the advertisement of RuYan is 
not in the category of tobacco product, there is no requirement for 
pre-approval by the agency.  State Administration for Industry and 
Commerce has noted related health concerns.  So we’ve asked the 
Ministry of Health, State Food and Drug Administration, and the 
State Administration of Work Safety, to carry out identification 
                                                                                                               
CHINA NAT’L HEALTH AND FAMILY PLANNING COMMISSION (May 29, 2006), http://
www.moh.gov.cn/wsb/pxwfb/200804/28081.shtml. 
30 The Regulation has a number of general requirements applicable to the production, 
storage, use, operation, and transportation of dangerous chemicals. 
31 For the Three Ministries’ response to the RuYan issue, see San Bumen Jiu Ruyan 
Wenti Zuochu Huiying, Ruyan Rengzai Miwu Zhong (三部门就“如烟”问题作出回应,
如烟仍在迷雾中) [Three Ministries Responded to "RuYan" Issue, and Ruyan Is Still in the 
Mist], PEOPLE'S DAILY ONLINE (Dec. 1, 2006), http://politics.people.com.cn/GB/1027/
5116023.html (reporting that the manufacture and sales of RuYan shall be regulated under 
dangerous chemicals regulations because RuYan contains nicotine, which is listed in the 
dangerous chemicals checklist). 
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testing.”32  Officials from the State Food and Drug Administration 
stated that they had never approved any e-cigarette as either a 
pharmaceutical product or a medical device.  In June 2006, the 
agency issued a document explicitly stating that nicotine electronic 
vaporizers were used for eliminating smokers’ physiological needs 
for nicotine and easing withdrawal symptoms, and that such devices 
did not fit under the regulatory framework developed for medical 
devices in China.33  RuYan had become the proverbial hot potato, and 
no regulatory agency was willing to risk getting burned. 
Almost ten years have passed since RuYan was brought to 
market, and little regulatory progress has been made.  As of May 2016, 
no government agency in China has taken responsibility for 
regulating e-cigarettes.  Instead, as e-cigarettes grow in popularity 
within and beyond China, and Chinese manufacturers continue to 
produce most of the world’s e-cigarette devices, the relevant 
government agencies seem anxious to make the regulation of e-
cigarettes someone else’s affair.  
In the absence of regulations in China that treat e-cigarettes 
as medical devices, pharmaceutical products, or tobacco products, 
they are considered ordinary consumer products, subject to litigation 
under the Product Quality Law34 and the Tort Liability Law.35  The 
Product Quality Law,36 enacted in 1993, includes general provisions 
that govern the manufacturing process, including product labeling 
requirements, product adulteration, and counterfeit products.  The 
2010 Tort Liability Law 37  includes specific product liability 
                                                                                                               
32 Id. (stating that if RuYan is identified as a tobacco product or tested toxic, the agency 
will definitely ban advertising; if the company continues to advertise, the agency will 
investigate and deal with it according to relevant laws). 
33 For the applicable government notice that is administratively binding, see Guanyu 
Baixibao Huisheng Xitong Deng Chanpin Fenlei Jieding De Tongzhi (关于白细胞回升系
统等产品分类界定的通知) [A Notice About the Product Classification of Recovery System 
of Leukocytes] (promulgated by China Food and Drug Administration, June 18, 2006), art. 
41, http://www.sfda.gov.cn/WS01/CL0845/10571.html. 
34 Zhonghua Renmin Gongheguo Zhipin Pinzhi Fa (中华人民共和国制品品质法) 
[Product Quality Law of the People's Republic of China] (promulgated by the Standing 
Comm. Nat’l People's Cong., Feb. 22, 1993, effective Sept. 1, 1993, amended by the 
Standing Comm. Nat’l People's Cong. on July 8, 2000), http://www.npc.gov.cn/wxzl/wxzl/
2000-12/05/content_4578.htm (China). 
35 Zhonghua Renmin Gongheguo Qinquan Zeren Fa (中华人民共和国侵权责任法) 
[Tort Liability Law of the People's Republic of China] (promulgated by the Standing 
Comm. Nat’l People's Cong., Dec. 26, 2009, effective July 1, 2010), http://www.gov.cn/
flfg/2009-12/26/content_1497435.htm. 
36 Product Quality Law, supra note 34. 
37 Tort Liability Law, supra note 35. 
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provisions, as well as other provisions that enable consumers to sue 
for personal injuries.  Although it may be sensible to treat e-cigarettes 
as ordinary consumer products in a tort law context, that approach 
cannot substitute for public health regulation.  If e-cigarettes pose 
health risks that can endanger users and bystanders, ex post tort 
remedies are likely to fail to achieve the appropriate level of public 
health protection.  Moreover, tort litigation imposes a significant cost 
on plaintiffs, both in terms of time and money, and could result in 
limited or no compensation due to the large number of small and 
possibly undercapitalized e-cigarette manufacturers.  
The rising popularity of e-cigarettes in China and the 
country’s dominance as a global e-cigarettes producer make China’s 
regulatory paralysis particularly troubling as a matter of global public 
health.  Chinese children can purchase e-cigarettes with ease, e-
liquids are widely available in different flavors and with varying 
quantities of nicotine, the public use of e-cigarettes is unrestricted, 
and manufacturing standards are extremely weak.  These concerns 
have not been entirely lost on the media.  Indeed, in 2011 the People's 
Daily Online noted, “there are large numbers of counterfeit e-
cigarette products on the market with little safety guarantee, the 
industry in China is in chaos.”38   Recent articles in the Southern 
Weekend and The New York Times have also highlighted the absence 
of e-cigarette regulations in China, the lack of quality control 
standards, the existence of heavy metals in e-cigarettes, and the risk 
of exploding products.39 
What, then, should be done?  Should e-cigarettes be regulated 
aggressively and kept out of the hands of consumers?  Or, given the 
well-known and profoundly negative impact of combustible tobacco 
products on public health, should e-cigarettes be regulated more 
modestly, with the hope that they will reduce the use of conventional 
cigarettes and thus improve public health?  In short, should Chinese 
                                                                                                               
38 See Dianziyan HangyeLuanxiang Dai Bian (电子烟行业乱象待“变”) [The E-
cigarette Industry’s Chaos Are Waiting for Changes], PEOPLE'S DAILY ONLINE (Dec. 14, 
2011), http://finance.people.com.cn/stock/GB/222942/16603305.html 
39 David Barboza, China’s E-Cigarette Boom Lacks Oversight for Safety, N.Y. TIMES 
(Dec. 13, 2014), http://www.nytimes.com/2014/12/14/business/international/chinas-e-
cigarette-boom-lacks-oversight-for-safety-.html; Xinxingyan Dingxing Buming, Baiwan 
Shichang Wu Jianguan (新型烟定性不明,百亿市场无监管) [Unknown Classification of 
the New E-cigarettes Left Ten Billion Yuan Market Unregulated], SOUTHERN WEEKEND 
(Aug. 1, 2014), http://www.infzm.com/content/102764. 
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regulators embrace the precautionary principle, or is harm reduction 
the better approach? 
To make that determination, it is instructive to look at how 
other nations are regulating e-cigarettes.  Indeed, Chinese regulators 
have recognized both the practical and rhetorical power of invoking 
foreign models, pointing to how other nations are regulating e-
cigarettes in order to support their domestic policy preferences.40  
Two examples are particularly illuminating; the United States, which 
issued regulations in May 2016 that treat e-cigarettes as tobacco 
products, and Japan, which is regulating them as pharmaceutical 
products.  As the old Chinese proverb goes, “there are other hills 
whose stones are good for working jade.”  In addressing the question 
of e-cigarette regulation, Chinese policy makers should be aware of 
what regulators elsewhere are doing as they move toward developing 
their own regulations.  
 
III. E-CIGARETTE REGULATION IN THE U.S. AND JAPAN 
 
A. United States 
 
The U.S. e-cigarette saga began in October 2008, when the 
FDA detained an inbound shipment of electronic cigarettes at the Los 
Angeles International Airport. 41   Two companies, NJOY and 
Smoking Everywhere, were importing the e-cigarettes from China 
with the intention of selling them in the United States, but the FDA 
thwarted their plans by claiming that nicotine-containing e-cigarettes 
could not enter the United States without FDA approval.  In the 
FDA’s view, nicotine was a drug as defined in the Food, Drug, and 
Cosmetic Act (FDCA), and e-cigarettes therefore had to be evaluated 
by the FDA for safety and efficacy, like all drugs marketed in the 
                                                                                                               
40 Li Baojiang (李保江), Quanqiu Dianziyan Shichang Fazhan, Zhuyao Zhengyi ji 
Shichang Guanzhi (全球电子烟市场发展,主要争议及政府管制) [A Global Perspective 
on the Future Development of Electronic Cigarettes and Related Controversial and 
Regulatory Issues], 20 ACTA TABACARIA SINICA, no. 4, 2014, at 101, 101. 
41  See FDA Fighting for Authority to Regulate Electronic Cigarettes, AM. ACAD. 
FAMILY PHYSICIANS (Mar. 2, 2010), http://www.aafp.org/news/health-of-the-public/
20100302e-cig-fda.html (detailing the FDA’s appeal to regulate e-cigarettes as drug delivery 
devices, rather than as tobacco products and providing background on the FDA’s detainment 
of e-cigarette shipments at the Los Angeles Airport); Electronic Cigarettes and the FDA, 
ELECTRONIC CIGARETTE SPOT, http://electroniccigarettespot.com/book/export/html/9 (last 
visited Feb. 20, 2015). 
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United States. 42   According to FDA Commissioner Margaret 
Hamburg, “[t]he FDA is concerned about the safety of these products 
and how they are marketed to the public.”43 
Not surprisingly, e-cigarette importers aggressively fought 
back.  In their view, e-cigarettes could not be regulated under the 
FDCA unless therapeutic claims were made on their behalf, such as 
their utility as smoking cessation aids.  Since importers had not made 
such claims, they argued that their products did not fall within the 
FDA’s jurisdiction over pharmaceutical products.  Instead, they 
insisted that the FDA could only regulate e-cigarettes under its 
authority to regulate tobacco products, an authority that Congress had 
only recently granted to the agency.44  Importers demanded that the 
FDA put a halt to the detention of their products, and sued the FDA 
in the D.C. Circuit Court.45 
U.S. District Court Judge Richard Leon’s ruling in the case, 
later affirmed on appeal, offered a sharp rebuke to the FDA’s position 
and provided the plaintiff e-cigarette companies, and the e-cigarette 
industry more generally, an open door to the cultivation of a U.S.-
based e-cigarette market.46  In Judge Leon’s view, the FDA could 
only regulate e-cigarettes as drugs or drug delivery devices if they 
were marketed with claims about their therapeutic effects.47  In all 
other cases, he ruled, the FDA could only regulate e-cigarettes by 
invoking its jurisdiction over tobacco products.48 
The District Court’s opinion, affirmed on appeal, left the FDA 
in a difficult position.  The U.S. Tobacco Control Act defines 
“tobacco product” as any product “made or derived from tobacco” 
that is not a “drug,” “device,” or combination product under the Act.  
                                                                                                               
42 21 U.S.C. § 360d (1938). 
43  Food and Drug Administration, FDA and Public Health Experts Warn About 
Electronic Cigarettes, U.S. FOOD AND DRUG ADMIN. (July 22, 2009), http://www.fda.gov/
newsevents/newsroom/pressannouncements/ucm173222.htm. 
44  See Tobacco Control Act, U.S. FOOD AND DRUG ADMIN., http://www.fda.gov/
TobaccoProducts/GuidanceComplianceRegulatoryInformation/ucm298595.htm (last 
visited Feb. 23, 2015) (describing how the Tobacco Control Act of 2009 gives the FDA 
broad authority to regulate the manufacture, distribution, and marketing of tobacco products).  
See also Family Smoking Prevention and Tobacco Control Act, Pub. L. No. 111-31, 123 
Stat. 1776 (2009). 
45 Smoking Everywhere, Inc. v. FDA, 680 F. Supp. 2d 62, 72 (D.D.C. 2010), aff’d sub 
nom; Sottera, Inc. v. Food & Drug Admin., 627 F.3d 891 (2010). 
46 Id. 
47 Id. at 72–75. 
48 Id. at 77. 
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It permits the FDA to regulate conventional tobacco products as well 
as other tobacco products that the Agency “by regulation deems to be 
subject to the law.”  The language is convoluted, but the direction is 
clear: the FDA must first bring e-cigarettes into its regulatory orbit 
by “deeming” them to be “tobacco products;” it can then regulate 
them as it sees fit, so long as its specific regulations do not run afoul 
of the Act. 
In April 2014, more than four years after the District Court’s 
decision, the FDA announced that it would extend its regulatory 
authority over tobacco to e-cigarettes and other “tobacco products,” 
such as cigars and hookah.49  Under the FDA’s proposed regulations, 
e-cigarette manufacturers will be required to provide the FDA with a 
list of product ingredients, submit all “new” products for FDA review, 
refrain from claims about the reduced risk posed by their products, 
and not distribute free samples.50  The FDA will also apply three key 
tobacco control regulations to e-cigarettes: age restrictions on sales, 
health warnings on packs, and limitations on vending machine 
sales.51 
As with all proposed agency regulations in the United States, 
the FDA was required to publish its proposed regulations in the 
Federal Register and seek public comment.  In a clear sign of the 
extraordinarily high degree of public and corporate interest in the 
FDA’s approach to e-cigarettes, the publication of the FDA’s 
deeming regulations garnered over 135,000 comments.  The FDA 
spent two years reviewing those comments, and in May 2016 
announced a Final Rule that fundamentally reaffirms the provisions 
contained in the proposed regulations.52 
Three important points emerge from the U.S. experience.  
First, the government had a clear preference for regulating e-
                                                                                                               
49 Heidi Ledford, FDA Proposes Regulation of Electronic Cigarettes, NATURE (Apr. 24, 
2014), http://www.nature.com/news/fda-proposes-regulation-of-electronic-cigarettes-1.151
05. 
50 Id. 
51 Id. 
52 Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic 
Act, as Amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions 
on the Sale and Distribution of Tobacco Products and Required Warning Statements for 
Tobacco Products, 81 Fed. Reg. 28,973 (May 10, 2016).  During the FDA’s long period of 
inaction, many states and municipalities stepped into the breach and enacted a wide variety 
of local e-cigarette controls, such as purchasing age limits, and public and/or work place 
bans. 
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cigarettes as pharmaceutical products; treating them as tobacco 
products came at the insistence of the court, and was not the FDA’s 
regulatory strategy.  Second, having been forced by the court to 
regulate e-cigarettes as tobacco products, the FDA has crafted a 
precautionary policy that imposes a number of restrictions on e-
cigarettes and could (depending upon subsequent regulatory 
interpretation and implementation) significantly limit the availability 
of e-cigarettes.53  Third, in the absence of sufficient data about the 
health risks of e-cigarettes and about whether e-cigarettes are more 
likely to be a gateway to the use of combustible tobacco products or 
an effective NRT, the FDA’s approach has been criticized as both too 
restrictive and too lax. 
 
B. Japan 
 
The Ministry of Finance has long held the legal authority to 
regulate tobacco products in Japan, and it continues to be the 
controlling shareholder of Japan’s only tobacco corporation, Japan 
Tobacco.54  Article 1 of the Tobacco Business Law, which governs 
Japan’s tobacco industry and articulates its tobacco policy, highlights 
the importance of “promoting the sound development of the Japanese 
tobacco industry, thereby securing national revenues.” 55   Political 
support by the agricultural sector (within which tobacco farmers have 
been influential) for Japan’s long-dominant political party, the 
Liberal Democratic Party, has muted political support for regulations 
that might decrease domestic tobacco consumption and sharpen the 
regulatory strategy toward tobacco products. 56   Perhaps not 
surprisingly, the Ministry of Health, Labor and Welfare (MHLW) has 
limited power when it comes to tobacco control, which further helps 
                                                                                                               
53 Among the important issues that will be clarified over the next two years is the 
number of e-cigarette products that the FDA will determine to be “substantially equivalent” 
to products marketed in the United States prior to February 15, 2007, which enables such 
products to avoid the potentially costly and time-consuming process of pre-market 
authorization.  
54 Eric A. Feldman, The Landscape of Japanese Tobacco Policy: Law, Smoking and 
Social Change, 49 AM. J. COMP. L. 679, 681–682 (2001). 
55 Tabako Jigyō Hō (たばこ事業法) [Tobacco Business Act], Law No. 68 of 1984 
(Japan). 
56 See Eric A. Feldman, The Culture of Legal Change: A Case Study of Tobacco 
Control in 21st Century Japan, 27 MICH. J. INT’L L. 743, 746–747 (2006) (analyzing how 
the political economy of tobacco in Japan explained the absence of laws involving tobacco 
consumption). 
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to explain Japan’s weak of tobacco control policies.  Given this 
institutional history, the question raised by e-cigarettes in Japan is 
whether the Ministry of Finance will regulate them as tobacco 
products or the Ministry of Health, Labor, and Welfare will treat them 
as pharmaceutical products. 
In early December 2010, the MHLW announced that the 
Pharmaceutical Affairs Law would be applied to e-cigarettes. 
According to the Ministry, Article 2 of the 1984 Tobacco Business 
Act defines a “tobacco product” (製造たばこ) as a product that is 
constituted in whole or in part of tobacco leaves and is capable of 
being smoked, chewed or sniffed.57  In turn, “tobacco leaf” (葉たば
こ) is defined as the leaf of a tobacco plant, and a “tobacco plant” (た
ばこ) is a plant of the nicotiana genus (タバコ属).  That definition, 
according to the MHLW, makes clear that e-cigarettes vaporizing a 
nicotine-containing liquid are not tobacco products and cannot be 
regulated as such.  Instead, according to the MHLW, e-cigarettes, like 
other products that contain nicotine, should be regulated under the 
Pharmaceutical Affairs Law.  On December 27, 2010, the MHLW 
ordered local governments (prefectures and municipalities) to 
monitor the sale of e-cigarettes containing nicotine, to prohibit 
pharmacies from selling them, and to recall all nicotine-containing e-
cigarettes.58  The result is a de facto ban on e-cigarettes, at least until 
an e-cigarette company seeks regulatory approval from the MHLW 
on the basis that its product is safe and effective. 
There is, however, a wrinkle on the regulatory fabric.  The 
MHLW’s approach was aimed at e-cigarettes that vaporize nicotine-
containing liquid.  Some electronic cigarettes, however, vaporize 
tobacco leaf, not liquid.  Instead of being regulated as pharmaceutical 
products by the MHLW, such vaporizers qualify as tobacco products 
(since they contain tobacco leaf) and are regulated by the Ministry of 
Finance. 59   From a public health perspective, there is little 
justification for such a regulatory divide.  There is no evidence that 
leaf vaporizers pose fewer health concerns than liquid vaporizers, and 
                                                                                                               
57 Tobacco Business Act, supra note 55. 
58 Nikochin wo Ganyusuru Denshi Tabako ni Kansuru Kigai Boshi Sochi ni Tsuite (ニ
コチンを含有する電子タバコに関する危害防止措置について) [Harm Prevention 
Measures Related to Electronic Cigarettes Containing Nicotine], JAPAN MINISTRY OF 
HEALTH, LABOR AND WELFARE (Dec. 27, 2010), http://www.mhlw.go.jp/stf/houdou/2r98520
00000zlvf.html. 
59 Interviews with officials at the Japanese Ministry of Finance and the Ministry of 
Health, Labor and Welfare (Dec. 2014) (on file with author). 
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one can speculate that because tobacco leaf contains over seventy 
known carcinogens and leaf vaporizers operate at higher heat than 
liquid vaporizers, they may pose greater health risks.  But data are not 
the primary concern when it comes to tobacco control in Japan.  
Perhaps it is only a coincidence that Japan Tobacco did not have a 
liquid-vaporizing e-cigarette in its product line but had made a 
significant investment in a leaf vaporizer that it was ready to bring to 
the Japanese market.  Nonetheless, a regulatory strategy that imposes 
a de facto ban on liquid vaporizers and enables the sale of leaf 
vaporizers appears to satisfy the economic, political, and institutional 
interests that have long animated tobacco policy in Japan and 
maintained a powerful alliance between the Ministry of Finance, 
Japan Tobacco, and other key players.  
 
C. The US and Japanese Approaches to E-Cigarette 
Regulation: Implications for China 
 
What lessons, if any, do the U.S. and Japanese experiences 
hold for China?  At least three general points emerge from the 
preceding analysis.  First, e-cigarette regulation is likely to reflect 
prior institutional arrangements.  These include the legal definition of 
pharmaceutical and tobacco products, regulatory policy and politics, 
patterns of tobacco consumption and control, and the weighing of 
economic, political and health considerations in the crafting of public 
health policy.  Second, as the U.S. courts have made clear, the claims 
manufacturers make about e-cigarettes—that they are safe, for 
example—may be a critical factor in how they are regulated.  Third, 
uncertainty about the nature of e-cigarettes—what they should be 
called, how they work—has led regulators to treat them like their 
most obvious analog, combustible cigarettes, even though they are 
different in a variety of notable ways.  Policymakers in the U.S. and 
Japan have adopted different regulatory strategies, yet their 
differences are more a reflection of domestic power relations and 
politics than of reasoned policy analysis.  Chinese policymakers can 
benefit from understanding those differences, but they are left with 
the difficult task of having to identify a workable regulatory approach 
that is more attentive to public health than private and state profit.  
 
 
 
 
426 U. PA. ASIAN L. REV.                         [Vol. 11 
 
IV. CHINA’S REGULATORY OPTIONS 
 
A. Legal Definitions 
 
In considering China’s primary regulatory options—
regulating e-cigarettes as pharmaceutical or tobacco products—one 
must first examine the relevant Chinese laws governing those 
approaches. 
Article 2 of the 1991 China Tobacco Monopoly Law, 
modified in 2009, 2013, and 2015, defines “tobacco monopoly 
products” as including cigarettes, cigars, pipe tobacco, re-dried 
tobacco leaf, tobacco leaf, cigarette paper, cigarette filter rods, tow 
for cigarette, and cigarette manufacturing equipment.  It defines 
“tobacco products” as cigarettes, cigars, pipe tobacco, and re-dried 
tobacco leaf. 60   E-cigarettes do not naturally fit any of these 
categories.  For e-cigarettes to be folded into the Tobacco Monopoly 
Law, the nicotine extracted from tobacco leaf (all tobacco leaf in 
China is controlled by the Tobacco Monopoly Bureau) would itself 
have to be legally defined as a ‘tobacco product.”  In the absence of 
such a redefinition or interpretation, e-cigarettes will remain beyond 
the reach of China’s Tobacco Monopoly Law.  
China’s Drug Administration Law, enacted in 1984 and 
modified in 2001 and 2015, defines pharmaceutical products as 
“articles which are used in the prevention, treatment and diagnosis of 
human diseases and intended for the regulation of the physiological 
functions of human beings, for which indications, usage and dosage 
are established, including Chinese crude drugs, prepared slices of 
Chinese crude drugs, traditional Chinese medicine preparations, 
chemical drugs substances and their preparations, antibiotics, 
biochemical drugs, radioactive pharmaceuticals, serum, vaccines, 
blood products and diagnostic agents.“61  This definition establishes 
three criteria for a product to be considered a drug: it must be “used 
in the prevention, treatment and diagnosis of human diseases,” be 
“intended for the regulation of the physiological functions of human 
                                                                                                               
60 Yancao Zhuanmai Fa (烟草专卖法) [China Tobacco Monopoly Law] (promulgated 
by the Standing Comm. Nat’l People’s Cong., June 29, 1991, effective Jan. 1, 1992, amended 
Apr. 24, 2015), art. 2, http://www.tobacco.gov.cn/html/27/2701/270101/4830381_n.html. 
61 Yaopin Guangli Fa (药品管理法) [China Drug Administration Law] (promulgated 
by the Standing Comm. Nat’l People’s Cong., Feb. 28, 2001, effective Dec. 1, 2001, 
amended Apr. 24, 2015), art. 102, http://www.npc.gov.cn/npc/cwhhy/12jcwh/2015-04/25/
content_1934604.htm. 
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beings,” and have “established indications, usage and dosage.”  Do 
e-cigarettes fall under this definition?  As in the United States, that 
will at least in part depend upon the interpretation of the meaning of 
intent, as well as on how e-cigarettes are advertised and promoted.  
To the degree than Chinese e-cigarette corporations continue to 
market their products as smoking cessation aids or as healthy 
alternatives to smoking, they invite regulation under the Drug 
Administration Law.  But so far, regulators in that agency show no 
sign of action. 
Additionally, in the recently modified Regulations for the 
Supervision and Administration of Medical Devices enacted by the 
State Council, the definition of medical device emphasizes that a 
“medical device’s principal action in or on the human body is not 
achieved by means of pharmacology, immunology or metabolism.”62  
This definition may preclude e-cigarettes, the utility of which 
generally relies on the pharmacological efficacy of nicotine on human 
metabolism. 
In short, current legal provisions in China indicate that e-
cigarettes do not clearly fall under the definition of tobacco products, 
pharmaceuticals, or medical devices.  Regulating e-cigarettes in 
China will thus inevitably involve amending existing legislation, 
most likely by the Standing Committee of the National People’s 
Congress or through a binding judicial interpretation from the 
Supreme People's Court and the Supreme People's Procuratorate.  If 
such amendments are necessary, which types of amendments would 
be most desirable? 
 
B. Regulating E-Cigarettes as Pharmaceutical Products 
 
There are both theoretical and practical reasons to regulate e-
cigarettes as pharmaceuticals.  Theoretically, the precautionary 
principle invites the government, in the absence of sufficient 
scientific evidence that establishes the safety of a product, to adopt a 
relatively strict regulatory approach for the sake of public health.  
Given the scientific uncertainty about e-cigarettes, keeping them off 
                                                                                                               
62 The regulations make clear that a pharmacological, immunological or metabolic 
impact must be a secondary, not primary, function. 
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the market or strictly limiting their availability would seem a prudent 
precautionary approach.63 
Pragmatically, the fact that many manufactures in China 
promote their products by asserting that e-cigarettes are less harmful 
than combustible cigarettes and are helpful in smoking cessation also 
calls for preemptive regulation.  According to a content analysis of e-
cigarette manufacturers’ websites in China, health-related benefits 
were claimed most frequently (89%), followed by claims of no 
secondhand smoke exposure (78%) and utility for smoking cessation 
(67%).64  A search of Taobao.com using “e-cigarette” (电子烟) as 
the key word reveals that all twenty of the top e-cigarette products as 
of May 2015 are promoted with claims about “smoking cessation" or 
"harmlessness.”  (See the promotional pictures from the top three 
best-selling e-cigarettes on Taobao.com below.)65 
 
 
 
Illustration 1.  Title: XX E-cigarettes are popular everywhere.  The six small signs 
refer to hotels, hospitals, schools, offices, airports and restaurants.  The caption 
states: “XX e-cigarettes not only assist in smoking cessation, but also solve the 
problem of smoking bans in public places like offices, schools, hospitals and 
restaurants, since they do not produce second hand smoke.”
66 
 
                                                                                                               
63 The precautionary approach in China is often discussed and has been adopted in 
environmental law and marine environmental protection in recent years.  See, e.g., Zhang 
Luoping (张珞平), et al., Yujing Yuanze Zai Huanjing Guihua Yu Guanli Zhong de Yingyong 
(预警原则在环境规划与管理中的应用) [Application of Precautionary Principle in 
Environmental Planning and Management], 43J. XIAMEN UNIV. (NATURAL SCIENCE) 221, 
221 (2004) (discussing the precautionary principle and its application in environmental 
planning and management). 
64  Tingting Yao et al., A Content Analysis of Electronic Cigarette Manufacturer 
Websites in China, 25 TOBACCO CONTROL 188, 188 (2016). 
65 Even Judge Richard Leon, whose opinion in the e-cigarette litigation made clear his 
distaste for government regulation, would have little trouble accepting the need for 
government regulations in the face of such unsubstantiated health claims.  
66 Downloaded from https://www.taobao.com (May 30, 2015). 
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Illustration 2.  Eight significant reasons to buy e-cigarettes.  The eight reasons as 
shown in the small pictures include no tobacco ash, no tar, various flavors, trendy 
and fashionable, assist in smoking cessation, effective smoking cessation, no 
second hand smoke, and portable.
67 
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Illustration 3.  Certificate of guarantee.  Many sellers assert that their products have 
been examined and/or approved by domestic and international institutions, like the 
CDC in China and the FDA in the U.S.  The picture displays certificates one seller 
claims to have received for its e-cigarettes.
68 
 
For Chinese policymakers to treat e-cigarettes as 
pharmaceuticals, the current legal definition of drugs will have to be 
modified.  Such modification may be on the way.  The Chinese Drug 
Administration Law, part of the National People’s Congress 
legislative reform program, is now being revised by the Chinese Food 
and Drug Administration and is expected to be completed before 
March 2018.  Some scholars have proposed that the CFDA should 
have the discretion to decide which substances should be deemed 
pharmaceutical products, in order to establish “the most stringent 
drug regulatory system” required by the Premier.  Indeed, the public 
online database of the CFDA includes twenty-four nicotine-based 
drugs for nicotine replacement therapy (twenty-two imported and two 
domestic) divided into five categories, including chewing gum, 
patches, transdermal agents, active pharmaceutical ingredients, and 
                                                                                                               
68 Id. 
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sublingual tablets.69  Clearly, some nicotine products in China have 
already been placed under the CFDA’s domain. 
If the CFDA is granted regulatory control of e-cigarettes, 
companies will be required to submit product applications with 
information on clinical trial data, product ingredients, dosage, and 
more.  An expert panel within CFDA will evaluate product safety, 
efficacy and other relevant indicators and make a decision about 
product approval.  Manufacturers, suppliers, and users will then be 
subject to a variety of supervision and inspection rules, such as the 
Good Manufacturing Practices in accordance with the Chinese Drug 
Administration Law.70  Ultimately, the CFDA could issue detailed 
standards for e-cigarettes.  Although high product quality is not 
produced merely by strict government regulation, a relatively strict 
review, approval, and supervision system can benefit consumers by 
providing at least better quality products.  In addition, existing 
pharmaceutical laws and regulations, such as drug labeling 
requirements, will apply to e-cigarettes and will help keep consumers 
informed.   
There are, however, some potential costs to regulating e-
cigarettes as pharmaceuticals.  First, for those e-cigarette 
corporations not making health claims about their products, it may be 
difficult to justify the imposition of pharmaceutical regulations.  If 
the presence of such claims invites regulation as a drug, surely the 
absence counters such regulation.  Second, there is a possibility that 
e-cigarettes will turn out to be an effective nicotine replacement 
therapy.  However, accumulating data that show safety and efficiency 
will take years, and during that time, many people’s health would be 
harmed by combustible tobacco products.  Finally, the Japanese 
approach to regulating e-cigarettes as pharmaceuticals provides a 
cautionary tale.  Even more so than Japan, the Chinese government 
retains a monopoly over the tobacco industry, and tobacco taxes and 
profits constitute a considerable proportion of both central and local 
                                                                                                               
69 The definition from China Drug Administration Law now decides what counts as a 
drug.  The CFDA has not been given the deeming power, i.e., defining a product as a drug 
merely out of CFDA’s own discretion. 
70 See, e.g., Zhonghua Renmin Gongheguo Yaopin Guanli Fa (中华人民共和国药品
管理法) [Drug Administration Law of the People’s Republic of China] (promulgated by 
the Standing Comm. Nat’l People’s Cong., Sept. 20, 1984, amended Feb. 28, 2001), art. 9, 
http://www.sda.gov.cn/WS01/CL0064/23396.html (China). 
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government revenue.71  Even if e-cigarettes that contain nicotine are 
brought under the control of the CFDA, products that vaporize 
tobacco leaf could, as in Japan, be regulated by those responsible for 
the lax regulation of combustible tobacco products—namely China 
Tobacco, under the China Tobacco Monopoly Law.  Such an 
approach is unlikely to prioritize public health and could well lead to 
similar problems as those experienced under China’s “double-track” 
regulatory system in the food and drug area.72 
 
C. Regulating E-Cigarettes as Tobacco Products 
 
Regulating e-cigarettes as tobacco products would sidestep 
some of the potential problems inherent in the pharmaceutical 
approach.  Rather than justifying regulation by pointing to the 
representations made by e-cigarette manufactures, a tobacco control 
approach focuses on the public health consequences of e-cigarettes.  
Such a focus would regulate liquid and leaf vaporizers similarly, 
unless data on their public health impact counsel a different approach.  
The most significant benefit of regulating e-cigarettes as tobacco 
products will be realized if studies ultimately support the view that 
the use of e-cigarettes reduces morbidity and mortality caused by the 
use of combustible cigarettes.  Chinese smokers currently consume 
about one-third of all tobacco products smoked per annum globally, 
and as a result, over 1 million Chinese die annually from tobacco-
                                                                                                               
71  In 2014, tobacco tax combined with profit reached 1 trillion Yuan, which constituted 
over 6% of government revenue.  2015 Nian Quanguo Yancao Gongzuo Huiyi Xianchang 
Shishi Baodao (2015 年全国烟草工作会议现场实时报道) [Live Report of the 2015 
National Tobacco Conference], E. TOBACCO J. (Jan 15, 2015), http://www.eastobacco.
com/zxbk/wzzt/2015nqgycgzhuztbd/2015zbbd/201501/t20150114_354690.html; 2014 
Nian Caizheng Shouzhi Qingkuang (2014 年财政收支情况 ) [2014 Fiscal Balance], 
CHINESE GOV. NETWORK (Jan. 30, 2015), http://www.gov.cn/xinwen/2015-01/30/content_
2812441.htm.  See also Li, supra note 26 (emphasizing the importance of tobacco tax and 
profit to government revenue in China). 
72 Previously, governance over food and drugs in China was divided between several 
ministries, leading to an unclear division of responsibility among agencies.  Problems with 
food safety were generally attributed to such multiple governances.  In March 2013, at the 
beginning of the central government’s new term, it tried to create a unified and centralized 
food and drug regulatory system.  Guojia Shipin Yaopin Jianguan Zhongju Guapai Shipin 
Jianguan Buzai “Jiulong Zhishui” (国家食品药品监管总局挂牌食品监管不再“九龙治
水”) [State Food and Drug Administration Established; Food Supervision Is No Longer 
Responsibility-Diverse], XINHUA NEWS (Mar. 22, 2013), http://news.xinhuanet.com/2013-
03/22/c_115125786.htm. 
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related diseases. 73   Because regulating e-cigarettes as tobacco 
products generally results in control rather than prohibition, it could 
lead to the growing popularity of e-cigarettes, a drop in combustible 
tobacco use, and an overall improvement in public health. 
In order to regulate e-cigarettes as tobacco products, the 
definition of tobacco products under the China Tobacco Monopoly 
Law (the “CTML”) must be revised.  Because the CTML is a national 
code ratified by the Standing Committee of the National People’s 
Congress, the State Tobacco Monopoly Administration (the agency 
that manages the tobacco monopoly) is responsible for justifying the 
need for a legal change and drafting revisions.  Alternatively, drafting 
a new law could be avoided if the Supreme People's Court and 
Supreme People's Procuratorate issued a new judicial interpretation 
of the law.  Indeed, in 2013, the media reported that a new judicial 
interpretation of the China Tobacco Monopoly Law would soon place 
e-cigarettes under the tobacco monopoly system.74  However, no such 
judicial interpretation has yet been presented. 
In addition to the possibility that regulating e-cigarettes as 
tobacco products could help reduce tobacco-related morbidity and 
mortality in China, it also has significant financial implications for 
the government.  Tobacco monopoly income is a major source of 
government revenue; tobacco taxes combined with profit constitute 
over 6% of total government income. 75   At the regional level, a 
tobacco leaf tax (tax rate is 20%) flows directly to local government, 
together with 25% of the value-added tax (tax rate is 17%).76  In 
provinces like Yunnan and Guizhou, where tobacco is a pillar 
                                                                                                               
73 See Zhongguo Yancao Kongzhi Guihua (2012-2015 Nian) (中国烟草控制规划
（2012-2015 年）) [China Tobacco Control Plan (2012-2015)], CHINA TOBACCO, http://
www.tobacco.gov.cn/history_filesystem/2013yckz/ghqw-more.htm (last visited May 10, 
2016) (discussing a control plan for tobacco in China from the year 2012 to 2015). 
74 See Niandi Guojia Youwang Chutai Yancao Zhuanmai Sifa Jieshi Han Dianzi Yan  
(年底国家有望出台烟草专卖司法解释含电子烟) [Tobacco Monopoly Law Judicial 
Interpretation Hopefully Could Be Issued by the End of the Year, Which Would Include 
Electronic Cigarettes], PEOPLE.COM.CN (Dec. 4, 2013), http://js.people.com.cn/html/
2013/12/04/272979.html (discussing the possibility of issuance of a judicial interpretation of 
the Tobacco Monopoly Law in China). 
75 Li, supra note 26.  The central government collects a tobacco excise tax, a value-
added tax, and a certain amount of net profit from the China National Tobacco Corporation. 
76 Value-added tax is a kind of shared tax by central and local government in China.  
The tax rate is 17%.  Central government gets 75% of it, while local government gets 25%.  
See Bu Wei, Zhongguo Difang Caizheng Dui Yancao Shuishou de Yilai (中国地方财政对
烟草税收的依赖) [The Dependence of Local Finance on Tobacco Tax in China], CNKI 
(2014), http://cdmd.cnki.com.cn/Article/CDMD-80201-1014046237.htm. 
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industry, the tobacco leaf tax is particularly important.77  Regulating 
e-cigarettes as tobacco products would enable the Chinese 
government to potentially collect a large sum of tax and profit.  
Regardless of whether e-cigarettes turn out to be a gateway to or exit 
from the use of combustible tobacco products, they would become a 
significant generator of revenue for both the central and local 
government. 
Folding e-cigarettes into the government’s tobacco monopoly 
also presents a number of challenges.  By defining e-cigarettes as 
tobacco products and asserting government control, the legal status 
of hundreds of private e-cigarette factories and thousands of online 
and brick and mortar retailers will be called into question.  How, and 
how quickly, could China Tobacco absorb those companies or issue 
monopoly licenses?  Moreover, China Tobacco faces a steep learning 
curve in regulating e-cigarettes.  So far, it has little experience in 
regulating manufactures of vaporizers or e-liquids that contain 
various amounts of nicotine.  Doing so effectively requires research 
and planning in terms of equipment, personnel, and more.  In addition, 
particularly given the large number of Internet-based sellers, effective 
enforcement will be a challenge.  
Finally, regulating e-cigarettes as tobacco products begs the 
question of whether China has effectively regulated other tobacco 
products.  Unfortunately, the answer is no.  Formally, China signed 
the WHO’s Framework Convention on Tobacco Control in 
November 2003, and ratified it in August 2005.  In April 2007, the 
State Council approved the establishment of the “FCTC 
Implementation Inter-Ministerial Coordination Leading Group,” with 
members from the National Health and Family Planning Commission, 
State Tobacco Monopoly Administration, and other relevant 
ministries.78  Under the leadership of that group, efforts have been 
made to prohibit tobacco advertising in the mass media, ban tobacco 
                                                                                                               
77 Id. 
78See Guowuyuan Guanyu Tongyi Chengli Yancao Kongzhi Kuangjia Gongyue Lvyue 
Gongzuo Buji Xietiao Lingdao Xiaozu de Pifu (国务院关于同意成立烟草控制框架公约
履约工作部际协调领导小组的批复) [The State Council Agreed to Set up the FCTC 
Implementation Inter-Ministerial Coordination Leading Group],  CHINALAW.GOV.CN (Mar. 
30, 2010), http://www.chinalaw.gov.cn/article/fgkd/xfg/fgxwj/201003/20100300251040.
shtml (discussing the setting up of the FCTC Implementation Inter-Ministerial Coordination 
Leading Group and specifying the composition and functions of the group). 
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use in indoor public places, and forbid sales to minors.79  Moreover, 
under the China Tobacco Control Plan (2012-2015), more rigorous 
measures such as prohibiting smoking in public places, strengthening 
warnings on cigarette packets, and banning tobacco promotion and 
sponsorship are on the way.   
Nonetheless, tobacco control policy in China has long been 
criticized as weak and poorly enforced.80  Per capita smoking rates 
are high, second-hand smoke exposure is ubiquitous, youth access is 
widespread, and public education is poor.  Extending this weak 
tobacco control regime to e-cigarettes is a troubling prospect.  Further, 
China Tobacco’s goal is to improve sales and make a profit, and it 
has little interest in a more robust tobacco control policy.  Indeed, 
with an eye toward maximizing profit, one can easily imagine that 
China Tobacco will be inclined to promote the still-unclear benefits 
of e-cigarettes and minimize their potential risks. 
 
V. CONCLUSION 
 
The explosion in the growth of the e-cigarette industry, the 
popularity of e-cigarettes among consumers and their unclear impact 
on public health make e-cigarette regulation in China a necessity.  
While regulatory choices in the United States and Japan may be 
instructive for Chinese regulators, in neither country has e-cigarette 
regulation been free of controversy, and neither presents a ready-
made approach that can be applied to China.  The Chinese 
government can learn about e-cigarette regulation elsewhere and 
                                                                                                               
79 The Smoking Control Ordinance of Shenzhen Special Economic Zone focused on 
strengthening the enforcement of smoking-bans in public places.  It created six municipal 
agencies – Public Security Bureau, Urban Management Bureau, Transportation Commission, 
Health Supervision Bureau, Sports and Tourism Bureau, and Market Supervision Bureau – 
responsible for enforcing the Ordinance in their own domains.  From March 1 to December 
31, 2014, 100,253 public places were inspected and 8,675 people were administratively fined 
a total of ¥ 420,100.  Shenzhen, where the most aggressive smoking regulations were 
implemented in 2014, is seen as a model tobacco control city in China. 
80 See Hong Yu (洪宇), Zhongguo Kongyan Zhengce Bianqian: Jiyu Zhichi Lianmeng 
Kuangjia de Fenxi (中国控烟政策变迁:基于支持联盟框架的分析) [The Change of China 
Tobacco Control Policy: An Advocacy Coalition Framework-Based Analysis], 7.3 CHINESE 
J. HEALTH POL’Y 20, 20 (2014) (analyzing the historical changes in Chinese tobacco control 
policy).  See also Jun Lv, et al., Implementation of the WHO Framework Convention on 
Tobacco Control in Mainland China, 20 TOBACCO CONTROL 309, 309 (2011) (discussing 
how China has implemented the WHO FCTC on tobacco). 
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hopefully learn from those experiences.  But it must craft its own set 
of policies.  
As Chinese policy makers ponder their approach to e-
cigarette regulation, they should consider taking immediate action in 
several arenas.  First, the dubious health claims made by many (most) 
e-cigarette companies can and should be regulated under the China 
Advertising Law.  Promotional materials claiming that e-cigarettes 
will help people stop smoking and touting their safety can mislead 
consumers and harm public health.  The Advertising Law, revised in 
September 2015, includes several articles relevant to e-cigarette 
regulation.81  Article 4 requires that “advertisements must not contain 
false or misleading content and must not deceive or mislead 
consumers.” 82   Article 17 states that “except for medical, 
pharmaceutical, and medical device advertising, any other 
advertising related to the treatment of disease is prohibited; medical 
terms or other terms that may suggest that the product confused with 
pharmaceutical or medical device are prohibited.” 83   In addition, 
Article 28 defines false advertising as “false or misleading 
advertising content to deceive or mislead consumers.”84  The State 
Administration for Industry and Commerce is responsible for 
enforcing the Advertising Law, which applies to all consumer 
products.  In doing so, it can inspect, survey, inquire, require relevant 
certificates and documents, and demand the suspension of advertising.  
Failure to adequately police adverting exposes the State 
Administration for Industry and Commerce to potential legal liability. 
Second, China is the world’s e-cigarette factory, but it lacks 
adequate quality control standards.  Such standards should cover (but 
not be limited to) the raw materials used to manufacture e-cigarettes, 
the microchips that are placed into e-cigarettes, the types of batteries 
they use, the presence of heavy metals, and many other factors that 
can lead to manufacturing defects, design defects, and consumer 
harm.  In addition, China produces a significant amount of e-liquid, 
and that too is in need of quality controls that address the quality of 
                                                                                                               
81  Zhonghua Renmin Gongheguo Guanggao Fa ( 中 华 人 民共 和 国 广 告 法 ) 
[Advertising Law of the People's Republic of China] (promulgated by Standing Committee 
of the Nat’l People’s Cong., Apr. 24, 2015, effective Sept. 1, 2015), http://www.gov.cn/
zhengce/2015-04/25/content_2853642.htm (China). 
82 Id. 
83 Id. 
84 If e-cigarettes were legally defined as tobacco products or drugs, advertising would 
require governmental review and approval.  However, in the absence of a clear definition, 
the State Administration for Industry and Commerce has justified regulatory inaction.  Id. 
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the concentration of nicotine, the use of additives, and types of 
flavorings.  Quality control provisions can come from a number of 
sectors: industrial organizations can draft manufacturing codes of 
practice; individual companies may seek quality certificates from 
reliable third-party institutions; and government agencies such as the 
General Administration of Quality Supervision, Inspection, and 
Quarantine or the China Food and Drug Administration could 
together issue standards. 
Third, the regulation and use of e-cigarettes is inevitably tied 
to the regulation of combustible tobacco.  Pragmatism and public 
health both counsel that tobacco control measures in China should be 
strengthened as a precursor/companion to e-cigarette regulation.  One 
priority should be the regulation of underage sales.  The Law on 
Protection of Minors and the Law on Prevention of Juvenile 
Delinquency both state that “no business places may sell cigarettes or 
alcoholic drinks to minors.”85  The China Advertising Law prohibits 
tobacco advertising to minors, and the China Tobacco Monopoly 
Law discourages young people from smoking and forbids primary 
and middle school students to smoke.86  However, according to China 
National Radio, nearly half of all cigarette retailers do not post signs, 
as required under the law, stating that they do not sell tobacco 
products to minors, and middle school students can easily purchase 
tobacco products in shops near their schools.87  A more robust ban, 
with enforced legal penalties, would help limit tobacco consumption 
in China and set a useful baseline for e-cigarette regulation.  Other 
tobacco control measures, such as packet warnings, taxation, and 
bans on smoking in public places should also be pursued.  
Enforcement must also be a key component of a more vigorous 
tobacco control agenda.  
                                                                                                               
85 Article 2 of the Law on Protection of Minors states that minors refers to citizens under 
eighteen years old. Zhonghua Renmin Gongheguo Weichengnianren Baohu Fa (中华人民
共和国未成年人保护法) [Law on Protection of Minors of the People's Republic of China] 
(promulgated by the Standing Comm. Nat’l People’s Cong., Sept. 4, 1991, effective Jan. 1, 
1992), art. 2 (China). 
86 A more explicit ban on sales of cigarettes to juveniles would help to limit tobacco 
consumed in China, and would set a useful baseline for e-cigarettes. 
87 See Diaocha Cheng Woguo Jinban Yandian Dui Weichengnian Bu Shefang (调查称
我国近半烟店对未成年不设防) [Survey Shows Nearly Half of Tobacco Retailer Shops in 
China Take No Measures to Prevent Sales to Minors], CHINA.CNR.CN (June 25, 2015), 
http://china.cnr.cn/qqhygbw/20150625/t20150625_518955879.shtml (discussing the facts 
and reasons why many tobacco shops are undefended to minors). 
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Finally, future e-cigarette regulation in China should pay 
special attention to the impact and implication of China’s current 
smoking epidemic.  Tobacco consumption in China is extremely high, 
tobacco control policies are weak, and there is no sign that smoking 
rates in China are decreasing at a significant pace.  This environment, 
quite different than in the United States and Japan, may have 
meaningful implications for future e-cigarette regulation.  One 
possibility is that e-cigarettes should be regulated less aggressively in 
China than elsewhere because of the urgent need to lower tobacco 
consumption rates.  Harm reduction, in other words, may have greater 
urgency in China, and that urgency may persuade policymakers to err 
on the side of relatively permissive e-cigarette regulation.  The 
opposite approach may be equally persuasive; perhaps e-cigarettes 
should be regulated aggressively because they could further 
complicate or worsen China’s combustible tobacco consumption 
problem.  Whichever direction Chinese policymakers turn, they are 
likely to discover what is already apparent to their counterparts in the 
United States and Japan.  No approach to e-cigarette regulation is 
wholly satisfactory, but the worst approach is no approach at all. 
 
  
